GH Research PLC: H.C. Wainwright sees up to 177% price potential!
Reading Time: 2 minutes
Several experts among the top analyst comments are currently optimistic about GH Research PLC (GHRE) . On July 24, 2025, multiple analysts expressed optimism regarding GH Research. Jason Butler from Citizens JMP set a price target of $39 and rated the stock as "Buy". Patrick Trucchio from H.C. Wainwright also reaffirmed his "Buy" recommendation with an even higher price target of $40. The analyst from H.C. Wainwright noted that the company recently received feedback from the FDA regarding its Investigational New Drug (IND) application for GH001....
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
